Tuesday, September 29, 2026

 

The bustling molecular communities inside cells



New findings illuminate mechanisms of protein production, transport, and folding in bacterial cells, but also establish a new way to study cellular ‘cities’, exploring molecular ‘communities’ rather than molecules in isolation.




European Molecular Biology Laboratory

Mahamid-group_1

image: 

Scientists often think of cells as small bustling cities with parts that resemble factories and shipping systems. Two new publications probe more deeply into how those different elements interact.

view more 

Credit: Daniela Velasco/EMBL




Scientists have often thought of cells as small bustling cities with parts that resemble factories, power grids, and shipping systems. And while past research has illuminated what we know about the various individual components of these cell cities, it hasn’t had the tools to probe more deeply into how those different elements interact.

Researchers from Julia Mahamid’s EMBL Heidelberg research group, however, have tapped the power of cryo-electron tomography (cryo-ET) to do exactly this: visualise how different cellular processes are connected. Their latest findings are published in two papers in the journal Cell. 

“Both projects are essentially proofs of concept for this kind of analysis,” said Joe Dobbs, lead author on one of the two papers and a former PhD fellow in Mahamid’s group. He is currently working as a postdoctoral researcher at the Max Planck Institute for Brain Research in Frankfurt. “Rather than looking at a single type of molecule in isolation, both papers examine interactions between different cellular systems with a common thread of understanding how different processes are coordinated.”

Getting to know protein production better

Dobbs’s work with colleagues focused on imaging Mycoplasma pneumoniae bacteria using cryo-ET. Cryo-ET is a powerful imaging technique that allows scientists to see inside flash-frozen cells in 3D and in great detail, revealing structures of molecular machines.

The scientists used this technology to reconstruct high-resolution maps and count instances of the protein production machinery (ribosomes) in different functional states across hundreds of individual cells. Because proteins do much of what a cell needs to stay alive, understanding this process helps us learn how cells work, why diseases happen, and how to develop better medicines.

Among other findings, the scientists observed several new complexes that directly connect transcription – the process of producing mRNA from DNA – with translation, the process of producing proteins. This allowed them to better understand how protein production is regulated, to provide structural evidence for long-hypothesised ‘supercomplexes’, and to suggest new molecular mechanisms for how the intertwined processes are controlled.

Additionally, they found parts of the ribosome attached to the cell membrane even when they weren't producing proteins. Their results suggest that these subunits might detach from the membrane only when conditions allow a new round of protein production to begin. This behaviour is similar to what had been observed in mammalian cells decades ago, and the new findings suggest that such mechanisms may be conserved from bacteria to humans.

“I think of it as a city,” Dobbs said. “The molecular machines I work on are like little factories that produce things, while some of my colleagues have been studying systems that transport and process those products. Together, they form different parts of a living molecular community inside the cell – much like a city with different specialised activities all working together.”

This focus on the interaction between the molecular machines, rather than in isolation, is part of what makes the two papers novel.

Discovery of wholly new complexes at the cell’s border

Elsewhere in the Mahamid group, Rasmus Jensen was leading research on a system responsible for protein transportation and folding at the cell membrane. He wanted to better understand what happens to proteins after they’re produced. 

“Joe started with a biological question he wanted to answer,” Jensen explained. “I started from the opposite direction. We’d seen something interesting in the cell and worked backwards to figure out what it was, eventually discovering that it’s a new configuration of a molecular machine that helps proteins either be exported out of the cell or inserted into its membrane.”

By combining cryo-ET imaging, proteomics, and computational protein structure predictions, the team found that this machinery contains the well-known Sec-translocon, a protein channel in the cell membrane that acts like a doorway to move newly made proteins out of the cell, along with three previously unknown proteins that help these transported proteins fold into their correct functional shapes.

Cryo-ET allowed the researchers to create the most detailed images so far of the conserved part of the bacterial protein transport machinery. These images showed how proteins translated by ribosomes begin moving through the cell membrane and revealed that protein transport is closely linked to a newly discovered protein-folding system outside the cell in Mycoplasma pneumoniae.

“Working together with many colleagues at EMBL, we combined expertise in microbiology, proteomics, bioinformatics, structural biology, and integrative modelling,” said Mahamid, EMBL Group Leader and senior author on both papers. “This paper tells the entire story of the discovery process: visualising a new cellular machinery, identifying the genes and proteins, and figuring out how it all functions. That’s a remarkable achievement and opens new ways to identify new complexes and functions in different systems.”

From simple bacterial cells to more complex species

While the discoveries are interesting in their own right, these studies more importantly lay the conceptual foundation for future studies.

“In both Joe’s work and mine, we’ve started with what we’d call a minimal cell where everything is relatively simple,” Jensen said. “We’ve advanced what is conceptually possible in this minimal bacterium and established ways to apply these methods to more complex organisms.”

“The future is studying molecular communities,” Mahamid said. “Decades of structural biology done on isolated molecules provided us with detailed views of their structures and functions. In the past, we just didn’t have the technology to study their more complex interactions and cross-talk. This work points again to how cryo-ET is an enabling technology, allowing us to see new things and connectivity inside cells. Its ability to show us more seems only limited by our asking the right questions.”

 

JMIR publications named one of Canada’s top growing companies by The Globe and Mail for 2026



JMIR Publications
JMIR Publications Named One of Canada’s Top Growing Companies by The Globe and Mail for 2026

image: 

JMIR Publications is proud to announce that it has qualified for the 2026 Report on Business magazine ranking of Canada’s Top Growing Companies

view more 

Credit: JMIR Publications





(Toronto, ON, September 25, 2026) JMIR Publications is proud to announce that it has qualified for the 2026 Report on Business magazine ranking of Canada’s Top Growing Companies. Listed in the Professional category alongside 376 of the nation's most innovative businesses, JMIR Publications earned its place on the list with a 105% three-year revenue growth rate from 2022 to 2025.

This marks a continued trajectory of sustained growth for the company, which previously earned spots on the prestigious editorial ranking, including placing on the 2023 list.

“This recognition proves that independence and open science work,” says Sean Jeong, CEO of JMIR Publications. “Our growth is a direct result of the value we deliver to the scientific community. By keeping research open, transparent, and accessible, we provide a necessary alternative to large commercial publishers.”

This achievement belongs entirely to the global network of people powering the journals. The success is driven by the extraordinary talent of JMIR Publications' staff, the dedicated expertise of its editorial board members, and the thousands of world-class authors who entrust the publisher with their groundbreaking research. JMIR Publications extends a special thank you to its peer reviewers for their invaluable time and dedication. Through their commitment and high standards, JMIR Publications continues to drive the evolution of scientific publishing using innovative, quality-driven open science practices.

Looking ahead, JMIR Publications is uniquely positioned to capture the rising tide of global investment in digital health research and technology. As healthcare systems worldwide accelerate their adoption of digital solutions, funding for research in artificial intelligence, mobile health, and health informatics continues to increase. This steady expansion of the field drives an unprecedented volume of scientific inquiry. JMIR Publications is ready to support researchers, by ensuring that the latest breakthroughs in digital health are validated, published, and accessible to the global medical community.

 

About The Globe and Mail's Top Growing Companies Program

Canada's Top Growing Companies is an editorial ranking launched in 2019 by The Globe and Mail's Report on Business magazine. The program recognizes Canadian businesses by evaluating their three-year percentage growth in annual operating revenue. Capturing the boldest entrepreneurial achievements across the country, the complete list of winning businesses is published annually in print and online.

 

About JMIR Publications

JMIR Publications is a leading open access publisher of digital health research and a champion of open science. With a focus on author advocacy and research amplification, JMIR Publications partners with researchers to advance their careers and maximize the impact of their work. As a technology organization with publishing at its core, we provide innovative tools and resources that go beyond traditional publishing, supporting researchers at every step of the dissemination process. Our portfolio features a range of peer-reviewed journals, including the renowned Journal of Medical Internet Research.

To learn more about JMIR Publications, please visit jmirpublications.com or connect with us via X, LinkedIn, YouTube, Facebook, Bluesky, and Instagram.

Head office: 130 Queens Quay East, Unit 1100, Toronto, ON, M5A 0P6 Canada

Media contact: communications@jmir.org

The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.

JMIR news: Patient simulator robots, participation fraud in online research, and more



JMIR Publications






(Toronto, Sept 25, 2026) — JMIR Publications released six feature News and Perspectives articles this week, covering everything in digital health from patient simulator robots to a novel mobile app for patients to store their digital health records.

 

Inside Online Patient Support Communities

Patients of conditions with little medical recognition or support often turn to online groups and forums, reports Vanessa Nirode in "Online Patient Support Communities as Sources of Support, Risk, and Research for Rare or Contested Conditions". One such condition, People Allergic To Me—whose sufferers “are thought to emit odors or gases that produce allergic reactions … in people near them”—has a dedicated subreddit where individuals gather for advice, support, and a place to vent frustration. Speaking with researchers of PATM, social media, and mental health, Nirode discusses how these groups can provide their users with validation and community, but potentially also “perpetuate anger and hopelessness or expose participants to misinformation and even potential symptom reinforcement, contagion, or social transmission.” Human moderation or algorithmic misinformation tagging could help mitigate the risks, according to researcher Irene Sánchez Rodriguez.

 

How to Make Health Care Innovations Stick

Academic physician and professor Boon-How Chew breaks down what it takes to innovate in the third op-ed in his series: "Beyond Innovation Theater: Building the Conditions for Innovation in Health Care". He identifies three conditions necessary for successful innovation: psychological safety, distributed leadership, and cognitive sovereignty; all of these, Chew argues, has the effect of facilitating change at all levels of an organization. To actually put innovation into practice, Chew offers practical guidance to precisely define the problem to be addressed; involve people affected with cocreation and stakeholder input, including both patients and staff; use small-scale testing; and plan early on for how the change will be managed, writing: “Sustainable innovations require a clear route for long-term ownership and engagement.”

 

Mobile App Allows Patients to Store Own Digital Health Records

Fragmented health services and inconsistent digitization means that patients in underserved areas rely on paper medical records in their own possession. In "Putting Digital Health Records in Patients’ Hands: Savva and Health Information Exchange in Uganda", Sharon Muzaki reports on a consumer health app that allows users to digitize their medical records and store them on their devices, theoretically allowing them greater flexibility and interoperability across health services. It also employs a conversational AI layer—selected from twelve available models by the user—which allows them to interact with their records. Uganda, whose Health Information and Digital Health Strategic Plan and Health Information Exchange and Interoperability Guidelines lay out a framework for health service interoperability, is “one of the markets Savva intends to serve,” writes Muzaki. “Savva’s proposition is part of a broader shift toward putting health information directly in patients’ hands…But democratizing access to information is not the same as democratizing health care.” 

 

Patient Robots Train Rural Clinicians for Rare Emergencies

Anika Nayak reports on an emerging class of medical robotics in "How Lifelike Patient Simulators Are Training US Rural Care Teams for Emergencies". Rural clinicians may not have the opportunity to practice handling unusual emergencies during training, but patient robots like Guamard Scientific’s VICTORIA and Pediatric HAL—”wireless, tetherless manikins that blink, breathe, speak, and bleed in real time,”—allow them to rehearse “rare, high-stakes crises without a patient’s life at stake,” writes Nayak. For care teams that don’t have direct access to their own patient robots, initiatives like The Amon G. Carter Medical Simulation Training Center’s mobile unit and telesimulation trainings can bring the simulators to them. 


 

Participation Fraud in Online Research

Online survey research is useful for lowering participation barriers, but this method’s wide reach and web-based setting make it vulnerable to bots. Cliff Dominy takes a look at researchers’ efforts to protect their data integrity in "Participant Fraud: How Imposters and Bots Undermine Health Databases". As research increasingly moves to online data collection, bad actors looking to profit from participation incentives use malicious bots to answer surveys, requiring researchers to adjust their methods defensively. “The unwelcome reality,” writes Dominy, “is that the role of health researchers has expanded from improving patient care to playing cybercop.” Digital tech has created this problem, but it may also be the solution: website security measures, survey questions designed to trap or expose bots, and web monitoring strategies can identify and address participation fraud.

 

An Interview With Samir Grover

Simon Spichak interviews Scarborough Health Network gastroenterologist and educator Samir Grover, MD in "From Simulations to AI: Samir Grover on How Tech Can Enhance Medical Education". Grover’s interest in medical education and technology began when, as a trainee performing an endoscopic procedure on a patient with no prior hands-on practice, he had the idea to use flight simulators as a model for training doctors on risky procedures. In his current role as SHN’s executive vice president of academics, Grover navigates the changing scenery of AI’s integration into medical educational technology, speaking on his own research, potential risks of deskilling and never-skilling, and the importance of publishing negative research findings.

 

 


About JMIR Publications News and Perspectives

JMIR Publications is a leading open access publisher of digital health research. The News and Perspectives section is the newest addition to its portfolio, established to bring the rigor and integrity of academic publishing to scientific journalism. The section features well-researched, expert-driven content from the Scientific News Editor, Kayleigh-Ann Clegg, PhD, and a network of specialist JMIR Publications Correspondents to keep the digital health community informed, inspired, and ahead of the curve.

About JMIR Publications

JMIR Publications is a leading open access publisher of digital health research and a champion of open science. With a focus on author advocacy and research amplification, JMIR Publications partners with researchers to advance their careers and maximize the impact of their work. As a technology organization with publishing at its core, we provide innovative tools and resources that go beyond traditional publishing, supporting researchers at every step of the dissemination process. Our portfolio features a range of peer-reviewed journals, including the renowned Journal of Medical Internet Research. 

To find out more about JMIR Publications, visit jmirpublications.com or connect with them on Bluesky, X, LinkedIn, YouTube, Facebook, and Instagram.


The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.

 

UCF researcher investigates mechanisms of nicotine addiction



Through a National Institutes of Health grant, College of Medicine Assistant Professor Cali Calarco is investigating how brain cells respond to nicotine and influence behavior



UCF College of Medicine

Dr. Cali Calarco researches mechanisms of nicotine addiction

image: 

Dr. Cali Calarco researches mechanisms of nicotine addiction 

view more 

Credit: Credit UCF College of Medicine




UCF assistant professor and researcher at the Burnett School of Biomedical Sciences Cali Calarco is exploring how nicotine affects brain cells, providing insights that could ultimately help improve treatments for addiction.  

Through a nearly five-year, $943,000-plus grant from the National Institutes of Health, Calarco’s lab is examining how neurons — nerve cells in the brain — and their molecules change when exposed to nicotine and other drugs. The goal is to understand how microscopic changes in the brain eventually influence behavioral decisions, including those associated with addiction. 

“We want to understand what’s really influencing the neuron,” says Calarco, who began work on this project in 2024 as a postdoctoral scholar at the University of Maryland, Baltimore, before joining UCF in January as an assistant professor. “Which component is critical for the neuron function that leads to drug-seeking behavior?” 

For this research, Calarco’s lab is focused on the nucleus accumbens, an area of the brain involved in reward, learning and behavior.  

“I call it a little computer that integrates a lot of signals that come in relationship to reward learning from a lot of other parts of the brain to guide behavioral choices,” she says. 

The nucleus accumbens contains multiple types of brain cells, and Calarco’s research examines how individual cell types respond to nicotine and other drugs. Her lab is particularly interested in mitochondria, the structures within cells that produce the energy they need to function. Recent studies suggest mitochondria may also play an important role in drug-seeking behavior. 

“Mitochondria have been underappreciated in neurons previously,” she says. “Neurons are incredibly complex cells that do incredibly complex tasks, both electrically and chemically that require a ton of energy, so we knew they were really important. But mitochondria also influence how neurons communicate with each other. They’re super important for gene transcription and translation and for steroid hormone production.” 

By understanding addiction at the molecular level, researchers may ultimately be able to develop better treatments for substance use disorder.  

“There aren’t that many substance use disorder treatments, and the ones available only work for a subset of people,” she says. “There is room for improvement in nicotine use disorder therapies, and new pathway targets may provide more effective treatments with fewer side effects.” 

Nicotine use has persisted even as the products used to consume it have changed. Calarco compares the trend to a game of whack-a-mole, with new nicotine products gaining popularity as older ones decline. While cigarette smoking has declined, consumers now have access to products such as e-cigarettes and nicotine pouches placed between the lips and gum. According to data from the FDA and CDC’s 2025 National Youth Tobacco Survey, nicotine pouch use nearly quadrupled among U.S. youth and young adults between 2022 and 2025. 

While her research is focused on nicotine, Calarco says her findings could have implications for other substances and even social media addiction. 

Calarco earned her doctorate in neuroscience from Yale University before conducting postdoctoral research at the University of Maryland, Baltimore, where she studied mitochondria and cocaine-seeking behavior. She joined the UCF College of Medicine’s Burnett School of Biomedical Sciences in January 2026. 

------------------------------------------------------------------------------------------------------------------ 

Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number K01DA061048. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. 

Monday, September 28, 2026

 

First known case of Marfan syndrome discovered in feline siblings




Cornell University






Media note: Photos of Shaggy and Gary can be found and downloaded here.


ITHACA, N.Y. — Researchers at Cornell University have documented the first molecular characterization of Marfan syndrome in domestic cats in a paper in Scientific Reports.

As kittens, feline siblings Gary and Shaggy had noticeably longer limbs, and later examinations revealed problems with the structures of their eyes and enlargement of the aorta. That pointed veterinarians toward Marfan syndrome, a rare inherited disorder, seen mostly in humans, that weakens the body’s connective tissues. It affects about 1 in 4,000 people, but this was the first known documented case in cats.

“The findings provide a foundation for improved veterinary diagnostics,” said senior author Dr. Jacquelyn Evans, assistant professor in the College of Veterinary Medicine and at the Baker Institute for Animal Health. “It can help veterinarians recognize similar cases in the future and may help develop genetic tests.”

A multidisciplinary team combined detailed clinical evaluations with genetic sequencing to identify the gene responsible for the feline siblings’ condition: FBN1, which codes for a protein called fibrillin-1, a building block of the body’s connective tissues found throughout the body, including in blood vessels, bones, ligaments, skin and eyes.

Researchers found that both brothers carried two altered copies of the FBN1 gene, meaning they inherited a changed copy from each parent. In humans, just one altered copy of the FBN1 gene can cause Marfan syndrome. Inheriting two altered copies is extremely rare and can interfere with the body’s ability to produce normal fibrillin-1.

In the case of Gary and Shaggy, however, further investigation showed that the cats’ variant did not completely shut down the gene. Instead, it partially disrupted the way the gene’s instructions are processed, allowing some normal function to remain — explaining how the cats survived into adulthood despite carrying two copies of a variant that otherwise might have caused more severe disease.

For additional information, read this Cornell Chronicle story.

Cornell University has dedicated television and audio studios available for media interviews.

-30-

 

Get by with a little help from (old) friends



Chemical signatures in fossils indicate chemosymbiosis predates the Cambrian era.




Washington University in St. Louis






At the bottom of the deepest parts of the ocean, tube worms are living their best life thanks to help from their neighboring microbes, which oxidize the sulfide in the surrounding waters and detoxify the environment. The question is, how far back do these “old friends” go?

“There are a whole host of organisms that have these partnerships in the environment today,” said David Fike, the Glassberg/Greensfelder Distinguished University Professor of Earth, Environmental, and Planetary Sciences in Arts & Sciences at Washington University in St. Louis. He was speaking of chemosymbiosis, the process wherein microbes adjust the surrounding chemical environment to benefit the host animal.

“Previously, we didn’t know if that is a relatively recent evolutionary event, or if that emerged all the way back when animals first evolved,” he added.

The fossil record is sketchy when it comes to evidence of microbe and animal symbiosis. But modern earth science tools potentially can highlight chemical signatures that correlate with this form of symbiosis. Pyrite fossils from the seafloor can preserve those chemical signatures.

In collaborative research led by Nanjing University and published in Proceedings of the National Academy of Sciences, Fike and co-authors document how they found evidence in such fossils that chemosymbiosis is a very old trick of evolution, found in fossils from the Ediacaran Period, a time between 635 to 540 million years ago that predates the Cambrian explosion. The Ediacaran Period was when the first multicellular life evolved, and one reason such life may have evolved was microbial help making that toxic ocean a bit more hospitable.

In the new paper, Fike and his co-authors present geochemical data that suggests the proto-worms of the Ediacaran had the same symbiotic relationship with bacteria, sulfide and oxide as the tube worms of today.

 “It was a very early evolutionary strategy, one that helped animals survive and spread throughout the ocean,” Fike said.


Wang Z, Peng Y, Tang Q, Schiffbauer JD, Xiao S, Fike DA, Jia Z, Feng D, Crockford PW, Cai Y, Yuan X, Pratt LM. Chemosymbiotic trophic strategy in an Ediacaran tubular animal, Proc. Natl. Acad. Sci. U.S.A. 123 (35) e2526201123. https://doi.org/10.1073/pnas.2526201123

The work was supported by the National Natural Science Foundation of China (92479205, 424B2024, and 42525202); J.D.S. acknowledges NSF support (LET-2422405) and the University of Missouri Marie M. and Harry L. Smith endowment. S.X. acknowledges NSF support (DEB-2449384). Other support came from the Fundamental Research Funds for the Central Universities (0206/14380204, 0206/14380253, 0206/14380234, and 0206/14380237), the New Cornerstone Science Foundation through the XPLORER PRIZE (to Y.P.), Open Research Fund (2025-Z03) of State Key Laboratory of Critical Earth Material Cycling and Mineral Deposits of Nanjing University, and the “GeoX” Interdisciplinary Project of Frontiers Science Center for Critical Earth Material Cycling (20250201, 20250101).